Celebrating 25 years of Euretina.

Satellite Symposia

Satellite Symposia

Programme

Thursday, 4 September

Digital Visualisation IME Platform: Enhanced Precision and Outcomes in Retinal Surgery – From Innovation to Implementation

4 September, 13:30 – 14:30 CEST

Amphitheatre Bleu

Chairperson(s):
P. Udaondo, SPAIN
S. Priglinger, GERMANY

Roche Logo. Click to open company website (opens in new tab).

Real-World Decisions with Real-World Data

4 September, 13:30 – 14:30 CEST

Amphitheatre Bordeaux

Chairperson(s):
A. Khanani, USA

Ora Logo, below logo is text "The Ophthalmology Research Company". Click to open company website (opens in new tab).

Rethinking Retina: Building Smarter Clinical Trials for a Global Clinical Execution

4 September, 13:30 – 14:30 CEST

Room 252AB

Chairperson(s):
L. Schmetterer, AUSTRIA
K. Lane, USA

Evolving Practice in Retinal Care: The Journey From Lab to Patient 

4 September, 13:30 – 14:30 CEST

Room Maillot

Chairperson(s):
E. Souied, FRANCE
M. Munk, SWITZERLAND

EssilorLuxottica Logo. Click to open company website (opens in new tab).

Evolving Strategies in Myopia Management: New Perspectives and Evidence

4 September, 13:30 – 14:30 CEST

Amphitheatre Havane

Chairperson(s):
A. Couturier, FRANCE

Friday, 5 September

AbbVie Logo. Click to open company website (opens in new tab).

Spotlight on Inflammation: Evolving the Management of DME and RVO

5 September, 09:45 - 10:45 CEST

Amphitheatre Bordeaux

Chairperson(s):
L. Kodjikian, FRANCE

Alcon Logo. Click to open company website (opens in new tab).

Achieving Superior Efficiency 1-4* in Vitreoretinal Surgery
(1. Alcon Data on File, 2024. [REF-24644]; 2. Alcon Data on File, 2024. [REF-24379] 3. Alcon Data on File, 2024. [REF-24576]; 4. Alcon Data on File, 2024. [REF-24615]) 

5 September, 09:45 - 10:45 CEST

Regency AB

Chairperson(s):
S. Rizzo, ITALY

iCare, below logo is text "For better perception". Click to open company website (opens in new tab).

Advancing Retinal Imaging: Current Trends and Future Directions

5 September, 09:45 - 10:45 CEST

Room 252AB

Chairperson(s):
G. Querques, ITALY

Changing And Rethinking Vitreous And Retinal Treatments With Lasers

5 September, 09:45 - 10:45 CEST

Room Maillot

Chairperson(s):
M. Lupidi, ITALY

THROUGH OUR PATIENTS’ EYES: Patient Voices in the Era of Continuous Drug Delivery for Retinal Disease

5 September, 09:45 - 10:45 CEST

Amphitheatre Havane

Chairperson(s):
C. Awh, USA

From Data to Decisions: What do we See in the Real World?

5 September, 13:45 - 14:45 CEST

Amphitheatre Bleu

Chairperson(s):
C. Bailey, UK

The nAMD Challenge: Looking Beyond VEGF-A Inhibition

5 September, 13:45 - 14:45 CEST

Amphitheatre Bordeaux

Chairperson(s):
F. Holz, GERMANY

Innovations in Imaging – Transforming Patient Care

5 September, 13:45 - 14:45 CEST

Room 252AB

Chairperson(s):
C. Mody, GERMANY
M. Teussink, GERMANY

Geographic Atrophy Patient Management: What Do You See? What Would You Do?

5 September, 13:45 - 14:45 CEST

Room Maillot

Chairperson(s):
A. Loewenstein, ISRAEL

Optos Logo. Click to open company website (opens in new tab).

Enhancing Patient Care Through Innovation: The Power of Ultra-widefield Imaging and Navigated Peripheral OCT

5 September, 13:45 - 14:45 CEST

Room 352AB

Chairperson(s):
S. Sadda, USA

TowardPi Medical Logo. Click to open company website (opens in new tab).

TowardPi! How 400kHz OCT/OCTA Change Practice

5 September, 17:45 - 18:45 CEST

Amphitheatre Bleu

Chairperson(s):
J. Zhou, CHINA

Microclear Medical Instruments Logo. Click to open company website (opens in new tab).

SKY Launch, Odyssey From Retina To Cornea

5 September, 17:45 - 18:45 CEST

Room 252AB

Chairperson(s):
A. Cusumano, ITALY

Amgen Logo. Click to open company website (opens in new tab).

Decoding Biosimilars and Biosimilar Development

5 September, 17:45 - 18:45 CEST

Room Maillot

Chairperson(s):
R. Gale, UK

ESPANSIONE MARKETING SPA Logo. Click to open company website (opens in new tab).

Light Modulation™ LLLT (PBM): A New Frontier in Retinal Care & Beyond

5 September, 17:45 - 18:45 CEST

Amphitheatre Havane

Chairperson(s):
D. Zur, ISRAEL
R. Mastropasqua, ITALY
D. Bacherini, ITALY

Saturday, 6 September

Advocating for Innovative Therapies: Everything you Need to Know

6 September, 10:15 - 11:15 CEST

Amphitheatre Bordeaux

Chairperson(s):
I. Pearce, UK

4D Molecular Therapeutics Logo. Click to open company website (opens in new tab).

Intravitreal Gene Therapy: A New Era of Durable Treatment for Retinal Vascular Diseases with 4D-150

6 September, 10:15 - 11:15 CEST

Regency C

Chairperson(s):
A. Khanani, USA
A. Loewenstein, ISRAEL
B. Kuppermann, USA
D. Pieramici, USA
G. Cheung, USA

Photobiomodulation Therapy for Dry AMD: Insights from 4.5 Years of Follow-up from the LIGHTSITE IIIB Trial

6 September, 10:15 - 11:15 CEST

Room 252AB

Chairperson(s):
Q. Dong Nguyen, USA

Illuminating Diabetic Retinopathy: Using Diagnostic Imaging and Advanced Surgical Visualization to Enhance Patient Care

6 September, 10:15 - 11:15 CEST

Room Maillot

Chairperson(s):
A. Couturier, FRANCE

Ocular Therapeutix Logo, "Retina experience redefined". Click to open company website (opens in new tab).

Advancing Retinal Disease Treatment: Exploring OTX-TKI’s Potential to Extend Treatment Durability

6 September, 10:15 - 11:15 CEST

Amphitheatre Havane

Chairperson(s):
P. Schlottmann, ARGENTINA

The Time is Now: Lead the Way to Shape the Future

6 September, 13:00 - 14:00 CEST

Amphitheatre Bleu

Chairperson(s):
A. Loewenstein, ISRAEL

Roche Logo. Click to open company website (opens in new tab).

The DME Challenge: Looking Beyond VEGF-A Inhibition

6 September, 13:00 - 14:00 CEST

Amphitheatre Bordeaux

Chairperson(s):
S. Sadda, USA

Canon Medical Systems Europe Logo. Click to open company website (opens in new tab).

Beyond the Central Retina: The Impact of Ultra-Widefield OCT & OCT-A

6 September, 13:00 - 14:00 CEST

Room 252AB

Chairperson(s):
C. Dinah, UK
T. Aslam, UK

AbbVie Logo. Click to open company website (opens in new tab).

Personalised Treatment for the Right Patient at the Right Time: Advances in AI-driven optimization of outcomes in DME and RVO

6 September, 13:00 - 14:00 CEST

Room Maillot

Chairperson(s):
L. Kodjikian, FRANCE

Diagnostic Pursuits Using Advanced Insights into Morphologic Changes in Chorioretinal Disease

6 September, 13:00 - 14:00 CEST

Amphitheatre Havane

Chairperson(s):
T. Ach, GERMANY

Digital Visualisation IME Platform: Enhanced Precision and Outcomes in Retinal Surgery – From Innovation to Implementation

4 September, 13:30 – 14:30 CEST

Amphitheatre Bleu

Chairperson(s):
P. Udaondo, SPAIN
S. Priglinger, GERMANY

Roche Logo. Click to open company website (opens in new tab).

Real-World Decisions with Real-World Data

4 September, 13:30 – 14:30 CEST

Amphitheatre Bordeaux

Chairperson(s):
A. Khanani, USA

Ora Logo, below logo is text "The Ophthalmology Research Company". Click to open company website (opens in new tab).

Rethinking Retina: Building Smarter Clinical Trials for a Global Clinical Execution

4 September, 13:30 – 14:30 CEST

Room 252AB

Chairperson(s):
L. Schmetterer, AUSTRIA
K. Lane, USA

Evolving Practice in Retinal Care: The Journey From Lab to Patient 

4 September, 13:30 – 14:30 CEST

Room Maillot

Chairperson(s):
E. Souied, FRANCE
M. Munk, SWITZERLAND

EssilorLuxottica Logo. Click to open company website (opens in new tab).

Evolving Strategies in Myopia Management: New Perspectives and Evidence

4 September, 13:30 – 14:30 CEST

Amphitheatre Havane

Chairperson(s):
A. Couturier, FRANCE

AbbVie Logo. Click to open company website (opens in new tab).

Spotlight on Inflammation: Evolving the Management of DME and RVO

5 September, 09:45 - 10:45 CEST

Amphitheatre Bordeaux

Chairperson(s):
L. Kodjikian, FRANCE

Alcon Logo. Click to open company website (opens in new tab).

Achieving Superior Efficiency 1-4* in Vitreoretinal Surgery
(1. Alcon Data on File, 2024. [REF-24644]; 2. Alcon Data on File, 2024. [REF-24379] 3. Alcon Data on File, 2024. [REF-24576]; 4. Alcon Data on File, 2024. [REF-24615]) 

5 September, 09:45 - 10:45 CEST

Regency AB

Chairperson(s):
S. Rizzo, ITALY

iCare, below logo is text "For better perception". Click to open company website (opens in new tab).

Advancing Retinal Imaging: Current Trends and Future Directions

5 September, 09:45 - 10:45 CEST

Room 252AB

Chairperson(s):
G. Querques, ITALY

Changing And Rethinking Vitreous And Retinal Treatments With Lasers

5 September, 09:45 - 10:45 CEST

Room Maillot

Chairperson(s):
M. Lupidi, ITALY

THROUGH OUR PATIENTS’ EYES: Patient Voices in the Era of Continuous Drug Delivery for Retinal Disease

5 September, 09:45 - 10:45 CEST

Amphitheatre Havane

Chairperson(s):
C. Awh, USA

From Data to Decisions: What do we See in the Real World?

5 September, 13:45 - 14:45 CEST

Amphitheatre Bleu

Chairperson(s):
C. Bailey, UK

The nAMD Challenge: Looking Beyond VEGF-A Inhibition

5 September, 13:45 - 14:45 CEST

Amphitheatre Bordeaux

Chairperson(s):
F. Holz, GERMANY

Innovations in Imaging – Transforming Patient Care

5 September, 13:45 - 14:45 CEST

Room 252AB

Chairperson(s):
C. Mody, GERMANY
M. Teussink, GERMANY

Geographic Atrophy Patient Management: What Do You See? What Would You Do?

5 September, 13:45 - 14:45 CEST

Room Maillot

Chairperson(s):
A. Loewenstein, ISRAEL

Optos Logo. Click to open company website (opens in new tab).

Enhancing Patient Care Through Innovation: The Power of Ultra-widefield Imaging and Navigated Peripheral OCT

5 September, 13:45 - 14:45 CEST

Room 352AB

Chairperson(s):
S. Sadda, USA

TowardPi Medical Logo. Click to open company website (opens in new tab).

TowardPi! How 400kHz OCT/OCTA Change Practice

5 September, 17:45 - 18:45 CEST

Amphitheatre Bleu

Chairperson(s):
J. Zhou, CHINA

Microclear Medical Instruments Logo. Click to open company website (opens in new tab).

SKY Launch, Odyssey From Retina To Cornea

5 September, 17:45 - 18:45 CEST

Room 252AB

Chairperson(s):
A. Cusumano, ITALY

Amgen Logo. Click to open company website (opens in new tab).

Decoding Biosimilars and Biosimilar Development

5 September, 17:45 - 18:45 CEST

Room Maillot

Chairperson(s):
R. Gale, UK

ESPANSIONE MARKETING SPA Logo. Click to open company website (opens in new tab).

Light Modulation™ LLLT (PBM): A New Frontier in Retinal Care & Beyond

5 September, 17:45 - 18:45 CEST

Amphitheatre Havane

Chairperson(s):
D. Zur, ISRAEL
R. Mastropasqua, ITALY
D. Bacherini, ITALY

Advocating for Innovative Therapies: Everything you Need to Know

6 September, 10:15 - 11:15 CEST

Amphitheatre Bordeaux

Chairperson(s):
I. Pearce, UK

4D Molecular Therapeutics Logo. Click to open company website (opens in new tab).

Intravitreal Gene Therapy: A New Era of Durable Treatment for Retinal Vascular Diseases with 4D-150

6 September, 10:15 - 11:15 CEST

Regency C

Chairperson(s):
A. Khanani, USA
A. Loewenstein, ISRAEL
B. Kuppermann, USA
D. Pieramici, USA
G. Cheung, USA

Photobiomodulation Therapy for Dry AMD: Insights from 4.5 Years of Follow-up from the LIGHTSITE IIIB Trial

6 September, 10:15 - 11:15 CEST

Room 252AB

Chairperson(s):
Q. Dong Nguyen, USA

Illuminating Diabetic Retinopathy: Using Diagnostic Imaging and Advanced Surgical Visualization to Enhance Patient Care

6 September, 10:15 - 11:15 CEST

Room Maillot

Chairperson(s):
A. Couturier, FRANCE

Ocular Therapeutix Logo, "Retina experience redefined". Click to open company website (opens in new tab).

Advancing Retinal Disease Treatment: Exploring OTX-TKI’s Potential to Extend Treatment Durability

6 September, 10:15 - 11:15 CEST

Amphitheatre Havane

Chairperson(s):
P. Schlottmann, ARGENTINA

The Time is Now: Lead the Way to Shape the Future

6 September, 13:00 - 14:00 CEST

Amphitheatre Bleu

Chairperson(s):
A. Loewenstein, ISRAEL

Roche Logo. Click to open company website (opens in new tab).

The DME Challenge: Looking Beyond VEGF-A Inhibition

6 September, 13:00 - 14:00 CEST

Amphitheatre Bordeaux

Chairperson(s):
S. Sadda, USA

Canon Medical Systems Europe Logo. Click to open company website (opens in new tab).

Beyond the Central Retina: The Impact of Ultra-Widefield OCT & OCT-A

6 September, 13:00 - 14:00 CEST

Room 252AB

Chairperson(s):
C. Dinah, UK
T. Aslam, UK

AbbVie Logo. Click to open company website (opens in new tab).

Personalised Treatment for the Right Patient at the Right Time: Advances in AI-driven optimization of outcomes in DME and RVO

6 September, 13:00 - 14:00 CEST

Room Maillot

Chairperson(s):
L. Kodjikian, FRANCE

Diagnostic Pursuits Using Advanced Insights into Morphologic Changes in Chorioretinal Disease

6 September, 13:00 - 14:00 CEST

Amphitheatre Havane

Chairperson(s):
T. Ach, GERMANY